Kara M. Hoar

2.7k total citations
18 papers, 1.6k citations indexed

About

Kara M. Hoar is a scholar working on Molecular Biology, Cell Biology and Oncology. According to data from OpenAlex, Kara M. Hoar has authored 18 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Molecular Biology, 10 papers in Cell Biology and 7 papers in Oncology. Recurrent topics in Kara M. Hoar's work include Microtubule and mitosis dynamics (9 papers), Ubiquitin and proteasome pathways (5 papers) and Cancer-related Molecular Pathways (5 papers). Kara M. Hoar is often cited by papers focused on Microtubule and mitosis dynamics (9 papers), Ubiquitin and proteasome pathways (5 papers) and Cancer-related Molecular Pathways (5 papers). Kara M. Hoar collaborates with scholars based in United States and Russia. Kara M. Hoar's co-authors include Jeffrey Ecsedy, Deborah R. Wysong, Arijit Chakravarty, Jessica J. Huck, Mengkun Zhang, Mark Manfredi, Patrick Leroy, Douglas Bowman, Christopher F. Claiborne and Todd B. Sells and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Nature Communications.

In The Last Decade

Kara M. Hoar

18 papers receiving 1.6k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Kara M. Hoar United States 14 1.1k 879 780 315 140 18 1.6k
Madhavi Bandi United States 11 1.2k 1.1× 744 0.8× 734 0.9× 236 0.7× 49 0.3× 20 1.9k
Robert J. Ingham Canada 21 936 0.9× 238 0.3× 409 0.5× 362 1.1× 35 0.3× 34 1.5k
Jonathan Grim United States 8 1.7k 1.6× 331 0.4× 766 1.0× 168 0.5× 44 0.3× 9 2.1k
Patrick Leroy United States 10 575 0.5× 622 0.7× 421 0.5× 64 0.2× 105 0.8× 12 983
Martin Schwickart United States 11 1.2k 1.1× 420 0.5× 365 0.5× 169 0.5× 18 0.1× 22 1.4k
Carol Y. Ying United States 14 1.5k 1.4× 229 0.3× 545 0.7× 349 1.1× 31 0.2× 15 2.0k
Mala Mani United States 11 1.1k 1.0× 400 0.5× 413 0.5× 132 0.4× 40 0.3× 15 1.4k
Luis Toledo Denmark 14 2.5k 2.3× 454 0.5× 1.2k 1.6× 101 0.3× 32 0.2× 18 2.7k
Yan Degenhardt United States 16 1.1k 1.0× 362 0.4× 663 0.8× 99 0.3× 39 0.3× 23 1.6k
Lyuben Tsvetkov United States 14 1.4k 1.3× 426 0.5× 1.1k 1.4× 194 0.6× 16 0.1× 19 1.8k

Countries citing papers authored by Kara M. Hoar

Since Specialization
Citations

This map shows the geographic impact of Kara M. Hoar's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kara M. Hoar with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kara M. Hoar more than expected).

Fields of papers citing papers by Kara M. Hoar

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kara M. Hoar. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kara M. Hoar. The network helps show where Kara M. Hoar may publish in the future.

Co-authorship network of co-authors of Kara M. Hoar

This figure shows the co-authorship network connecting the top 25 collaborators of Kara M. Hoar. A scholar is included among the top collaborators of Kara M. Hoar based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kara M. Hoar. Kara M. Hoar is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Jiang, Lei, Ling Yin, Eric Jacquinet, et al.. (2020). Dual mRNA therapy restores metabolic function in long-term studies in mice with propionic acidemia. Nature Communications. 11(1). 5339–5339. 91 indexed citations
2.
Sells, Todd B., Ryan Chau, Jeffrey Ecsedy, et al.. (2015). MLN8054 and Alisertib (MLN8237): Discovery of Selective Oral Aurora A Inhibitors. ACS Medicinal Chemistry Letters. 6(6). 630–634. 83 indexed citations
3.
Gavin, James M., Kara M. Hoar, Qing Xu, et al.. (2014). Mechanistic Study of Uba5 Enzyme and the Ufm1 Conjugation Pathway. Journal of Biological Chemistry. 289(33). 22648–22658. 34 indexed citations
4.
Milhollen, Michael A., Darshan S. Sappal, Kara M. Hoar, et al.. (2014). 577 Characterization of the cellular mechanism of action of the first in class investigational inhibitor of the Ubiquitin Activating Enzyme, MLN7243. European Journal of Cancer. 50. 186–186. 7 indexed citations
5.
Blackburn, Christopher, Janice E. Chin, Dylan B. England, et al.. (2014). Histone deacetylase inhibitors derived from 1,2,3,4-tetrahydropyrrolo[1,2-a]pyrazine and related heterocycles selective for the HDAC6 isoform. Bioorganic & Medicinal Chemistry Letters. 24(23). 5450–5454. 13 indexed citations
6.
Blackburn, Christopher, Janice E. Chin, Kenneth M. Gigstad, et al.. (2013). Potent Histone Deacetylase Inhibitors Derived from 4-(Aminomethyl)-N-hydroxybenzamide with High Selectivity for the HDAC6 Isoform. Journal of Medicinal Chemistry. 56(18). 7201–7211. 37 indexed citations
7.
Manfredi, Mark, Jeffrey Ecsedy, Arijit Chakravarty, et al.. (2011). Characterization of Alisertib (MLN8237), an Investigational Small-Molecule Inhibitor of Aurora A Kinase Using Novel In Vivo Pharmacodynamic Assays. Clinical Cancer Research. 17(24). 7614–7624. 242 indexed citations
8.
Sappal, Darshan S., Neil Bence, Paul Fleming, et al.. (2011). Cellular and biochemical characterization of an inhibitor of the Ubiquitin Activating Enzyme (UAE). 2. 1 indexed citations
9.
Huck, Jessica J., Mengkun Zhang, Alice McDonald, et al.. (2010). MLN8054, an Inhibitor of Aurora A Kinase, Induces Senescence in Human Tumor Cells Both In vitro and In vivo. Molecular Cancer Research. 8(3). 373–384. 103 indexed citations
10.
Wysong, Deborah R., Arijit Chakravarty, Kara M. Hoar, & Jeffrey Ecsedy. (2009). The inhibition of Aurora A abrogates the mitotic delay induced by microtubule perturbing agents. Cell Cycle. 8(6). 876–888. 54 indexed citations
11.
Sells, Todd B., Jeffrey Ecsedy, Stephen G. Stroud, et al.. (2008). MLN8237: an orally active small molecule inhibitor of Aurora A kinase in phase I clinical trials. Cancer Research. 68. 237–237. 14 indexed citations
12.
Leroy, Patrick, John Hunter, Kara M. Hoar, et al.. (2007). Localization of Human TACC3 to Mitotic Spindles Is Mediated by Phosphorylation on Ser558 by Aurora A: A Novel Pharmacodynamic Method for Measuring Aurora A Activity. Cancer Research. 67(11). 5362–5370. 100 indexed citations
13.
Manfredi, Mark, Jeffrey Ecsedy, Kristan Meetze, et al.. (2007). Antitumor activity of MLN8054, an orally active small-molecule inhibitor of Aurora A kinase. Proceedings of the National Academy of Sciences. 104(10). 4106–4111. 334 indexed citations
14.
Hoar, Kara M., Arijit Chakravarty, Claudia Rabino, et al.. (2007). MLN8054, a Small-Molecule Inhibitor of Aurora A, Causes Spindle Pole and Chromosome Congression Defects Leading to Aneuploidy. Molecular and Cellular Biology. 27(12). 4513–4525. 164 indexed citations
15.
Manfredi, Mark, Jeffrey Ecsedy, Kristan Meetze, et al.. (2006). MLN8054, an orally active Aurora A kinase small molecule inhibitor in phase I clinical trials. Cancer Research. 66. 1110–1110. 5 indexed citations
16.
Vonderheide, Robert H., Susan M. Domchek, Joachim L. Schultze, et al.. (2004). Vaccination of Cancer Patients Against Telomerase Induces Functional Antitumor CD8+ T Lymphocytes. Clinical Cancer Research. 10(3). 828–839. 205 indexed citations
17.
Schmollinger, Jan C., Robert H. Vonderheide, Kara M. Hoar, et al.. (2003). Melanoma inhibitor of apoptosis protein (ML-IAP) is a target for immune-mediated tumor destruction. Proceedings of the National Academy of Sciences. 100(6). 3398–3403. 88 indexed citations
18.
Vonderheide, Robert H., Joachim L. Schultze, Karen S. Anderson, et al.. (2001). Equivalent induction of telomerase-specific cytotoxic T lymphocytes from tumor-bearing patients and healthy individuals.. PubMed. 61(23). 8366–70. 64 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Madhavi Bandi Breakdown of academic impact, for papers by Robert J. Ingham Breakdown of academic impact, for papers by Jonathan Grim Breakdown of academic impact, for papers by Patrick Leroy Breakdown of academic impact, for papers by Martin Schwickart Breakdown of academic impact, for papers by Carol Y. Ying Breakdown of academic impact, for papers by Mala Mani Breakdown of academic impact, for papers by Luis Toledo Breakdown of academic impact, for papers by Yan Degenhardt Breakdown of academic impact, for papers by Lyuben Tsvetkov
Rankless by CCL
2026